医療用バイオポリマー市場：タイプ別、ソース別、用途別-2023-2030年の世界予測

医療用バイオポリマー市場規模は2022年に19億8,000万米ドルと推定され、2023年には24億3,000万米ドルに達し、CAGR 23.22%で2030年には105億2,000万米ドルに達すると予測されます。

医療用バイオポリマーの世界市場

医療用バイオポリマー市場は、現代医療産業の絶え間なく進化する需要により、大きな成長を遂げています。これらの天然ポリマーや生物学的に合成されたポリマーは、生分解性ステント、ドラッグデリバリー・システム、縫合糸など、最先端の医療ツールや医療器具の製造に不可欠であり、いずれも人体との適合性、自然分解性、毒性の低さが評価されています。その用途は再生医療、医薬品、外科手術など多岐にわたります。市場拡大の原動力となっているのは、生体適合材料に対するニーズの急増、バイオポリマーの画期的な技術進歩、慢性疾患の有病率の上昇です。市場には、生産効率の向上や、刺激応答性などのスマートな機能特性を特徴とする新規バイオポリマーなど、有望なビジネスチャンスがあふれています。一方で当業界は、研究開発費の高騰、厳しい規制状況、合成ポリマーとの厳しい競合など、ある種の制約に直面しています。特定の医療ニーズに合わせたバイオポリマーの開発や、臨床用途に合わせた性能の最適化など、技術革新と研究が極めて重要であることは間違いないです。さらに、持続可能な生産方法を模索し、ヘルスケア企業と強い関係を築くことが、このエキサイティングな分野を発展させる上で重要です。

地域別の洞察

米国は、その強固な医療インフラにより、医療用バイオポリマーの消費と革新において最先端を走っています。先進的なヘルスケア施設、高齢者人口の増加、持続可能な素材への強いこだわりが需要を牽引しています。カナダの取り組みは米国と一致しており、生態系への影響と、高度創傷治療や整形外科におけるバイオポリマーの統合を強調しています。最新の特許、調査、投資の面からも、北米はバイオポリマー技術革新の生産地です。EU諸国は環境負荷の低減に積極的に取り組んでおり、医療分野でのバイオポリマー応用を積極的に支援しています。需要の多くは、この地域の医療機器や医療材料、特に環境に優しく持続可能な医療機器や材料に対する強力な規制の枠組みの影響を受けています。EUにおける最近の投資は、バイオポリマーに特化した研究機関に注ぎ込まれており、欧州特許庁のような機関では新しい特許が次々と発表され、ダイナミックな技術革新の状況を示しています。アジア太平洋のバイオポリマー市場では、中国、日本、インドが有力なプレーヤーです。この地域は、インドの手頃なヘルスケアソリューションから日本の高度医療技術まで、消費者ニーズが多様な市場を形成しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医療用バイオポリマー市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、医療用バイオポリマー市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-医療用バイオポリマー市場の市場規模および予測は？

2-医療用バイオポリマー市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-医療用バイオポリマー市場における技術動向と規制の枠組みは？

4-医療用バイオポリマー市場における主要ベンダーの市場シェアは？

5-医療用バイオポリマー市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医療機器やインプラントの製造におけるバイオポリマーの需要増加
    • 高度なイメージングおよび骨格組織特異的治療のためのバイオポリマーの採用拡大
    • 生体高分子の滅菌技術の開発
  • 抑制要因
    • バイオポリマーに関連するパフォーマンスの問題
  • 機会
    • バイオポリマーのイノベーションと持続可能な生産
    • がんにおけるナノ粒子ドラッグデリバリーシステムの普及
  • 課題
    • 合成バイオポリマーに関連する生体適合性の問題
• 市場セグメンテーション分析
  • タイプ：持続可能性への志向の高まりにより、バイオポリマーの医療応用への注目が強調されている
  • ソース：合成バイオポリマーは、生体適合性、生体機能性、機械的特性、分解速度、免疫原性が強化されているため、需要が高まっている
  • 用途：組織生成能力の向上による創薬や創傷の閉鎖での用途拡大
• 市場動向分析
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ
  • 特許分析と動向

第6章 医療用バイオポリマー市場：タイプ別

• バイオベースポリエチレン
• 生分解性デンプンブレンド
• バイオPC
• Bio-Pet
• バイオPUR
• セルロース誘導体
• Pha
• 再生セルロース

第7章 医療用バイオポリマー市場：ソース別

• 天然
• 合成

第8章 医療用バイオポリマー市場：用途別

• 生体吸収性スキャフォールド
• 歯科
• ドラッグデリバリーシステム
• ヒーリング製品
• 外科用インプラント装置
• 治療用画像処理
• 創傷閉鎖

第9章 南北アメリカの医療用バイオポリマー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の医療用バイオポリマー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの医療用バイオポリマー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 合併・買収
  • 受賞・表彰・拡大

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • BASF SE
  • Biesterfeld AG
  • BioPolymer GmbH & Co. KG
  • Blafar Ltd.
  • Corbion NV
  • Danimer Scientific, Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Geistlich Pharma AG
  • GELITA AG
  • Green Dot Bioplastics Inc.
  • HTL
  • HyMedPoly
  • Invibio Ltd. by Victrex PLC
  • ITV Denkendorf Product Service GmbH
  • Merck & Co., Inc.
  • NatureWorks LLC
  • Rodenburg Productie B.V.
  • Solvay S.A.
  • SolyPlus GmbH
  • Symatese
  • Tate & Lyle PLC
  • Thermo Fisher Scientific, Inc.
  • Toray Industries Inc.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
• FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2022 VS 2030
• FIGURE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
• FIGURE 7. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 8. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
• FIGURE 10. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 12. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 14. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 16. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 22. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BASED POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 15. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 57. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 60. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 66. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 69. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 72. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 75. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 78. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 81. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 84. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 91. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 94. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 97. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 103. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 106. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 109. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 112. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 115. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 118. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 124. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 127. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 130. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 136. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 139. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 142. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 145. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 148. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 151. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 153. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 154. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET LICENSE & PRICING

[184 Pages Report] The Biopolymers for Medical Applications Market size was estimated at USD 1.98 billion in 2022 and expected to reach USD 2.43 billion in 2023, at a CAGR 23.22% to reach USD 10.52 billion by 2030.

Global Biopolymers for Medical Applications Market

Biopolymer market for medical applications is experiencing significant growth owing to the ever-evolving demands of the modern healthcare industry. These natural or biologically synthesized polymers are essential in the creation of cutting-edge medical tools and devices, including biodegradable stents, drug delivery systems, and sutures, all admired for their compatibility with the human body, natural decomposition, and reduced toxicity. Their applications are diverse, spanning regenerative medicine, pharmaceuticals, and surgical procedures. Market expansion is fueled by the surging need for biocompatible materials, groundbreaking technological progression in biopolymers, and a rising prevalence of chronic diseases. The market teems with opportunities, promising advances in production efficiency and novel biopolymers featuring smart functional properties such as stimuli-responsiveness. Nevertheless, the industry faces certain constraints, including the steep costs of research and development, stringent regulatory landscapes, and stiff competition from synthetic polymers. Undoubtedly, innovation and research are pivotal, focusing on developing tailored biopolymers for specific medical needs and optimizing performance to align with clinical applications. Additionally, exploring sustainable production methods and forging strong relationships with healthcare entities will be instrumental in advancing this exciting field.

Regional Insights

The United States is at the forefront in the consumption and innovation of biopolymers for medical applications due to its robust medical infrastructure. The demand is driven by advanced healthcare facilities, a growing elderly population, and a strong focus on sustainable materials. Canadian efforts align with those of the US, emphasizing ecological impact and the integration of biopolymers in advanced wound care and orthopedics. In terms of latest patents, research and investment, North America is a productive ground for innovation in biopolymer technology. EU countries exhibit a robust commitment to reducing environmental impact, which translates to active support for biopolymer applications in the medical sector. Much of the demand is influenced by the region's strong regulatory framework for medical devices and materials, particularly those that are eco-friendly and sustainable. Recent investments in the EU are funneled into research institutions focusing on biopolymers, and institutions such as the European Patent Office showcase a steady stream of new patents, indicating a dynamic innovation landscape. In Asia Pacific's biopolymer market, China, Japan, and India are prominent players. The region presents a diverse market with consumer needs varying from affordable healthcare solutions in India to advanced medical technologies in Japan.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopolymers for Medical Applications Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopolymers for Medical Applications Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopolymers for Medical Applications Market, highlighting leading vendors and their innovative profiles. These include BASF SE, Biesterfeld AG, BioPolymer GmbH & Co. KG, Blafar Ltd., Corbion NV, Danimer Scientific, Inc., DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries AG, Geistlich Pharma AG, GELITA AG, Green Dot Bioplastics Inc., HTL, HyMedPoly, Invibio Ltd. by Victrex PLC, ITV Denkendorf Product Service GmbH, Merck & Co., Inc., NatureWorks LLC, Rodenburg Productie B.V., Solvay S.A., SolyPlus GmbH, Symatese, Tate & Lyle PLC, Thermo Fisher Scientific, Inc., and Toray Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Biopolymers for Medical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Bio-Based Polyethylene
  • Bio-degradable Starch Blends
  • Bio-PC
  • Bio-PET
  • Bio-PUR
  • Cellulose Derivatives
  • PHA
  • Regenerated Cellulose
• Source
  • Natural
  • Synthetic
• Application
  • Bioresorbable Scaffolds
  • Dentistry
  • Drug Delivery Systems.
  • Healing Products
  • Surgical Implant Devices
  • Therapeutic Imaging
  • Wound Closure
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopolymers for Medical Applications Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopolymers for Medical Applications Market?

3. What are the technology trends and regulatory frameworks in the Biopolymers for Medical Applications Market?

4. What is the market share of the leading vendors in the Biopolymers for Medical Applications Market?

5. Which modes and strategic moves are suitable for entering the Biopolymers for Medical Applications Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Biopolymers for Medical Applications Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
    • 5.1.1.2. Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
    • 5.1.1.3. Development of Sterilization Technology for Biopolymers
  • 5.1.2. Restraints
    • 5.1.2.1. Performance Issues Associated with the Biopolymers
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations and Sustainable Production of Biopolymers
    • 5.1.3.2. Proliferation of Nano-Particle Drug Delivery Systems in Cancer
  • 5.1.4. Challenges
    • 5.1.4.1. Biocompatibility Issues Associated with Synthetic Biopolymers
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
  • 5.2.2. Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
  • 5.2.3. Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of COVID-19
• 5.5. Cumulative Impact of Russia-Ukraine Conflict
• 5.6. Cumulative Impact of High Inflation
• 5.7. Porter's Five Forces Analysis
  • 5.7.1. Threat of New Entrants
  • 5.7.2. Threat of Substitutes
  • 5.7.3. Bargaining Power of Customers
  • 5.7.4. Bargaining Power of Suppliers
  • 5.7.5. Industry Rivalry
• 5.8. Value Chain & Critical Path Analysis
• 5.9. Regulatory Framework
• 5.10. Client Customization
  • 5.10.1. Patent Analysis & Trend

6. Biopolymers for Medical Applications Market, by Type

• 6.1. Introduction
• 6.2. Bio-Based Polyethylene
• 6.3. Bio-degradable Starch Blends
• 6.4. Bio-PC
• 6.5. Bio-PET
• 6.6. Bio-PUR
• 6.7. Cellulose Derivatives
• 6.8. PHA
• 6.9. Regenerated Cellulose

7. Biopolymers for Medical Applications Market, by Source

• 7.1. Introduction
• 7.2. Natural
• 7.3. Synthetic

8. Biopolymers for Medical Applications Market, by Application

• 8.1. Introduction
• 8.2. Bioresorbable Scaffolds
• 8.3. Dentistry
• 8.4. Drug Delivery Systems.
• 8.5. Healing Products
• 8.6. Surgical Implant Devices
• 8.7. Therapeutic Imaging
• 8.8. Wound Closure

9. Americas Biopolymers for Medical Applications Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biopolymers for Medical Applications Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biopolymers for Medical Applications Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. Merger & Acquisition
    • 12.3.1.1. DuPont Completes Acquisition of Spectrum Plastics Group
    • 12.3.1.2. Sanofi completes acquisition of Provention Bio, Inc.
  • 12.3.2. Award, Recognition, & Expansion
    • 12.3.2.1. Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. BASF SE
  • 13.1.2. Biesterfeld AG
  • 13.1.3. BioPolymer GmbH & Co. KG
  • 13.1.4. Blafar Ltd.
  • 13.1.5. Corbion NV
  • 13.1.6. Danimer Scientific, Inc.
  • 13.1.7. DuPont de Nemours, Inc.
  • 13.1.8. Eastman Chemical Company
  • 13.1.9. Evonik Industries AG
  • 13.1.10. Geistlich Pharma AG
  • 13.1.11. GELITA AG
  • 13.1.12. Green Dot Bioplastics Inc.
  • 13.1.13. HTL
  • 13.1.14. HyMedPoly
  • 13.1.15. Invibio Ltd. by Victrex PLC
  • 13.1.16. ITV Denkendorf Product Service GmbH
  • 13.1.17. Merck & Co., Inc.
  • 13.1.18. NatureWorks LLC
  • 13.1.19. Rodenburg Productie B.V.
  • 13.1.20. Solvay S.A.
  • 13.1.21. SolyPlus GmbH
  • 13.1.22. Symatese
  • 13.1.23. Tate & Lyle PLC
  • 13.1.24. Thermo Fisher Scientific, Inc.
  • 13.1.25. Toray Industries Inc.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing